Three specific gut bacteria in the occurrence and development of colorectal cancer: a concerted effort

被引:7
|
作者
Gong, Dengmei [1 ]
Adomako-Bonsu, Amma G. [2 ]
Wang, Maijian [3 ]
Li, Jida [1 ]
机构
[1] Zunyi Med Univ, Coll Publ Hlth, Inst Zoonosis, Zunyi, Guizhou, Peoples R China
[2] Univ Med Sch Schleswig Holstein, Inst Toxicol & Pharmacol, Kiel, Germany
[3] Zunyi Med Univ, Affiliate Hosp, Gastrointestinal Surg, Zunyi, Guizhou, Peoples R China
来源
PEERJ | 2023年 / 11卷
关键词
Gut microbiota; Enterotoxigenic Bacteroides fragilis; Genotoxic Escherichia coli; Fusobacterium nucleatum; COLON-TUMOR GROWTH; GERM-FREE RATS; FUSOBACTERIUM-NUCLEATUM; MICROBIOTA; TOXIN; CARCINOGENESIS; CELLS; 1,2-DIMETHYLHYDRAZINE; INFLAMMATION; PROGRESSION;
D O I
10.7717/peerj.15777
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Colorectal cancer (CRC), which develops from the gradual evolution of tubular adenomas and serrated polyps in the colon and rectum, has a poor prognosis and a high mortality rate. In addition to genetics, lifestyle, and chronic diseases, intestinal integrity and microbiota (which facilitate digestion, metabolism, and immune regulation) could promote CRC development. For example, enterotoxigenic Bacteroides fragilis, genotoxic Escherichia coli (pks+ E. coli), and Fusobacterium nucleatum, members of the intestinal microbiota, are highly correlated in CRC. This review describes the roles and mechanisms of these three bacteria in CRC development. Their interaction during CRC initiation and progression has also been proposed. Our view is that in the precancerous stage of colorectal cancer, ETBF causes inflammation, leading to potential changes in intestinal ecology that may provide the basic conditions for pks+ E. coli colonization and induction of oncogenic mutations, when cancerous intestinal epithelial cells can further recruit F. nucleatum to colonise the lesion site and F. nucleatum may contribute to CRC advancement by primarily the development of cancer cells, stemization, and proliferation, which could create new and tailored preventive, screening and therapeutic interventions. However, there is the most dominant microbiota in each stage of CRC development, not neglecting the possibility that two or even all three bacteria could be engaged at any stage of the disease. The relationship between the associated gut microbiota and CRC development may provide important information for therapeutic strategies to assess the potential use of the associated gut microbiota in CRC studies, antibiotic therapy, and prevention strategies.
引用
收藏
页数:26
相关论文
共 50 条
  • [1] Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer
    Gao, Renyuan
    Zhu, Yefei
    Kong, Cheng
    Xia, Kai
    Li, Hao
    Zhu, Yin
    Zhang, Xiaohui
    Liu, Yongqiang
    Zhong, Hui
    Yang, Rong
    Chen, Chunqiu
    Qin, Nan
    Qin, Huanlong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [2] The role of anaerobic bacteria in the development and prevention of colorectal cancer: A review study
    Mohammadi, Mehrdad
    Mirzaei, Hamed
    Motallebi, Mitra
    ANAEROBE, 2022, 73
  • [3] Role of Bacteria in the Development of Colorectal Cancer
    Thomas, Ryan M.
    CLINICS IN COLON AND RECTAL SURGERY, 2023, 36 (02) : 105 - 111
  • [4] Gut mucosal microbiota profiles linked to development of positional-specific human colorectal cancer
    Zhang, Chunze
    Ma, Mingqian
    Zhao, Zhenying
    Feng, Zhiqiang
    Chu, Tianhao
    Wang, Yijia
    Liu, Jun
    Wan, Xuehua
    AIMS MICROBIOLOGY, 2024, 10 (04): : 812 - 832
  • [5] Dysbiosis of gut microbiota in promoting the development of colorectal cancer
    Zou, Shaomin
    Fang, Lekun
    Lee, Mong-Hong
    GASTROENTEROLOGY REPORT, 2018, 6 (01): : 1 - 12
  • [6] Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer
    Fan, Xiaoyan
    Jin, Yuelei
    Chen, Guang
    Ma, Xueqiang
    Zhang, Lixia
    DIGESTION, 2021, 102 (04) : 508 - 515
  • [7] The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
    Sanchez-Alcoholado, Lidia
    Ramos-Molina, Bruno
    Otero, Ana
    Laborda-Illanes, Aurora
    Ordonez, Rafael
    Medina, Jose Antonio
    Gomez-Millan, Jaime
    Queipo-Ortuno, Maria Isabel
    CANCERS, 2020, 12 (06)
  • [8] Gut bacteria, host immunity, and colorectal cancer: From pathogenesis to therapy
    Li, Yuyi
    Peng, Jinjin
    Meng, Xiangjun
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (10)
  • [9] Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer
    Lin, Caizhao
    Cai, Xiaolu
    Zhang, Jing
    Wang, Weibing
    Sheng, Qinsong
    Hua, Hanju
    Zhou, Xile
    DIGESTION, 2019, 100 (01) : 72 - 78
  • [10] Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
    Tarashi, Samira
    Siadat, Seyed Davar
    Badi, Sara Ahmadi
    Zali, Mohammadreza
    Biassoni, Roberto
    Ponzoni, Mirco
    Moshiri, Arfa
    MICROORGANISMS, 2019, 7 (11)